Human Microbiome Market to Grow at a CAGR of 21.8% during 2018 – 2025

Human Microbiome Market to Grow at a CAGR of 21.8% during 2018 - 2025

“Human Microbiome Market”
The global human microbiome market accounted to US$ 257.30 Mn in 2017 and is expected to grow at a CAGR of 21.8% during the forecast period 2018 – 2025, to account to US$ 1,197.08 Mn by 2025.

The Human Microbiome Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.

The market for human microbiome is expected to grow as increasing incidence of lifestyle diseases, increasing focus on human microbiome therapies and growing technological advancements in metagenomics and next-generation sequencing are expected to fuel the market growth during the forecast period. 

Get PDF sample copy: https://www.theinsightpartners.com/sample/TIPBT00002233/

Major Human Microbiome market Players: 

• Enterome

• MicroBiome Therapeutics

• Rebiotix

• Yakult Honsha

• Osel

• Vedanta Biosciences

• Metabiomics Corporate

• Synthetic Biologics

• DuPont

• BiomX

The Human Microbiome Market – Global Analysis to 2025 is an expert compiled study which provides a holistic view of the market covering current trends and future scope with respect to product/service, the report also covers competitive analysis to understand the presence of key vendors in the companies by analyzing their product/services, key financial facts, details SWOT analysis and key development in last three years. Further chapter such as industry landscape and competitive landscape provides the reader with recent company level insights covering mergers and acquisitions, joint ventures, collaborations, new product developments/strategies taking place across the ecosystem. The chapters also evaluate the key vendors by mapping all the relevant products and services to exhibit the ranking/position of top 5 key vendors.

Key Elements that the report acknowledges:

• Market size and growth rate during forecast period.

• Key factors driving the Human Microbiome Market

• Key market trends cracking up the growth of the Human Microbiome Market

• Challenges to market growth.

• Key vendors of Human Microbiome Market

• Detailed SWOT analysis.

• Opportunities and threats faces by the existing vendors in global market

• Trending factors influencing the market in the geographical regions.

• Strategic initiatives focusing the leading vendors.

• PEST analysis of the market in the five major regions.

Inquire for discount: https://www.theinsightpartners.com/discount/TIPBT00002233/

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Human Microbiome market based on product and application. It also provides market size and forecast till 2027 for overall Human Microbiome market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America (SAM), which is later sub-segmented by respective countries and segments. The report evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend and provides exhaustive PEST analysis for all five regions.

Strategic Insights

Expansion and patent and license approvals were observed as the most adopted strategy in global human microbiome industry. Few of the recent expansions and license as well as patent approvals made by the players are listed below:

2018: In April, 2018, MicroBiome Therapeutics, LLC (MBT), announced the launch of BiomeBliss, a patented, first-in-class prebiotic dietary supplement specifically developed to support a healthy gastrointestinal (GI) microbiome.

2017: In June, 2017, Guangzhou Yakult Co., Ltd. in Guangdong Province, China, would start constructing the Foshan Plant in Foshan, Guangdong Province in July 2017 for production of the Yakult and Yakult Light.

Buy this report @ https://www.theinsightpartners.com/buy/TIPBT00002233/

Reason to Buy

– Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Human Microbiome Market.
– Highlights key business priorities in order to assist companies to realign their business strategies.
– The key findings and recommendations highlight crucial progressive industry trends in Human Microbiome Market, thereby allowing players to develop effective long term strategies. 
– Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
– Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
– Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation and industry verticals.

Media Contact
Company Name: The Insight Partners
Contact Person: Sam J
Email: Send Email
Phone: +1-646-491-9876
Address:Hadapsar
City: Pune
State: Maharashtra
Country: India
Website: https://www.theinsightpartners.com/reports/human-microbiome-market